Wei-Chun Lin
-
- Acupuncture Treatment Research Studies 4
- Complementary and Alternative Medicine Studies 3
-
- Electronic Health Records Systems 6
-
- Lung Cancer Treatments and Mutations 5
-
- Glaucoma and retinal disorders 4
-
- Biomedical Text Mining and Ontologies 4
-
- Clinical practice guidelines implementation 3
-
- Retinal Imaging and Analysis 3
- Co-authors
- Chao Hsing YehLung-Chang ChienDana H. BovbjergLiye ZouYang LiuJiajia YeKathryn M. AlbersNatalia E. Morone
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Wei-Chun Lin
37 papers receiving 500 citations
Peers
Comparison fields: 5 of 95
- Complementary and alternative medicine 109
- Pharmacology 90
- Health Informatics 7
- Rheumatology 58
- Oncology 105
Countries citing papers authored by Wei-Chun Lin
This map shows the geographic impact of Wei-Chun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chun Lin more than expected).
Fields of papers citing papers by Wei-Chun Lin
This network shows the impact of papers produced by Wei-Chun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chun Lin. The network helps show where Wei-Chun Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei-Chun Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 3 | |
| 8 | Medication List Extraction Using Natural Language Processing for Glaucoma Patients | 2021 | 1 |
| 9 | 2021 | 0 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 61 | |
| 12 | 2020 | 10 | |
| 13 | 2018 | 7 | |
| 14 | 2017 | 22 | |
| 15 | 2017 | 28 | |
| 16 | 2015 | 72 | |
| 17 | 2015 | 17 | |
| 18 | 2012 | 2 | |
| 19 | 2003 | 15 | |
| 20 | Ifosfamide-based chemotherapy for previously treated lung cancer patients. | 1998 | 1 |
About Wei-Chun Lin
Wei-Chun Lin is a scholar working on Health Information Management, Complementary and alternative medicine and Ophthalmology, having authored 41 papers that have together received 520 indexed citations. Recurring topics across this work include Electronic Health Records Systems (6 papers), Lung Cancer Treatments and Mutations (5 papers), Glaucoma and retinal disorders (4 papers), Biomedical Text Mining and Ontologies (4 papers), Acupuncture Treatment Research Studies (4 papers), Clinical practice guidelines implementation (3 papers), Retinal Imaging and Analysis (3 papers) and Complementary and Alternative Medicine Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (109 citations), Pharmacology (90 citations) and Health Informatics (7 citations). Wei-Chun Lin has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Chao Hsing Yeh, Lung-Chang Chien, Dana H. Bovbjerg, Liye Zou, Yang Liu, Jiajia Ye, Kathryn M. Albers, Natalia E. Morone, Chun-Ming Tsai and Reury-Perng Perng. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.